Novo-Emcure Semaglutide Deal Clever Counter To Indian Rivals, Follows Lilly-Cipla Pact

Shores Semaglutide Post Metsera Backoff

 
• By Vibha Ravi
  
Novo Nordisk And India's Emcure Have Struck A Deal For GLP-1 Semaglutide Wegovy
Novo Nordisk And India's Emcure Have Struck A Deal For GLP-1 Semaglutide (Shutterstock)

More from Deals

More from Business